IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

New IAVI paper makes the case for strengthening clinical and regulatory pathways to accelerate global access to monoclonal antibodies

May 10, 2023

Expanded access would benefit many in low- and middle-income countries.

Read more

IAVI Report

Keeping it all in perspective

May 9, 2023

A view from Zambia on the shifting landscape of HIV vaccine research and the enduring optimism that characterizes one researcher’s drive.

Read more

Scientific Publications

Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond

Read more

Features

IAVI Board member Wafaa El-Sadr honored

April 28, 2023

IAVI Board member and ICAP founder Wafaa El-Sadr recognized for her contributions to global health.

Read more

Scientific Publications

The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2

Read more

Podcasts

Impact Voices Episode 2: The People Behind The Science

April 17, 2023

In this episode, KAVI-ICR scientists, Marianne Mureithi, Ph.D., Walter Jaoko, M.D., Ph.D., Daniel Muema, Ph.D., and Terry Muhomah, Ph.D. share their personal stories and shed light on what motivates them to do what they do. They provide insights into how they balance their personal lives with their scientific pursuits and discuss the significant contributions of women in science. They also reveal interesting highlights from their work and share their experiences of navigating the highs and lows of scientific research. Join us for an intimate conversation with the people behind the science and discover what inspires these scientists to tackle one of the greatest public health challenges of our time. Stay tuned to Impact Voices as we continue to showcase the people, science, and network driving HIV prevention research in Africa.

Read more

Scientific Publications

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates

Read more

IAVI Report

What will it take to improve access to vaccines?

April 13, 2023

Work is underway but obstacles to vaccine procurement and delivery for the next pandemic loom large.

Read more